Supplementary Table 3 from RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer

PDF file, 59K, Percent mouse weight change after RKI-1447 treatment. ErbB2 mammary tumor transgenic mice were treated with RKI-1447 as described under Materials and Methods. Final percent change in weight was calculated for each mouse using the following formula; (Wf-W0)/W0*100; where W0= Initial weight (at the beginning of treatment) and Wf= Final weight (at the end of treatment).